JP2022529052A5 - - Google Patents

Info

Publication number
JP2022529052A5
JP2022529052A5 JP2021561852A JP2021561852A JP2022529052A5 JP 2022529052 A5 JP2022529052 A5 JP 2022529052A5 JP 2021561852 A JP2021561852 A JP 2021561852A JP 2021561852 A JP2021561852 A JP 2021561852A JP 2022529052 A5 JP2022529052 A5 JP 2022529052A5
Authority
JP
Japan
Prior art keywords
cyclopropyl
difluorophenyl
amine
purine
propylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021561852A
Other languages
English (en)
Japanese (ja)
Other versions
JP7588859B2 (ja
JP2022529052A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/060819 external-priority patent/WO2020212553A1/en
Publication of JP2022529052A publication Critical patent/JP2022529052A/ja
Publication of JP2022529052A5 publication Critical patent/JP2022529052A5/ja
Application granted granted Critical
Publication of JP7588859B2 publication Critical patent/JP7588859B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021561852A 2019-04-18 2020-04-17 グラム陰性細菌の感染、汚染、及びファウリングを予防及び治療するための新規ピリミジン誘導体 Active JP7588859B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19170003 2019-04-18
EP19170003.8 2019-04-18
EP19188639.9 2019-07-26
EP19188639 2019-07-26
PCT/EP2020/060819 WO2020212553A1 (en) 2019-04-18 2020-04-17 New pyrimidine derivatives for prevention and treatment of gram-negative bacterial infection, contamination and fouling

Publications (3)

Publication Number Publication Date
JP2022529052A JP2022529052A (ja) 2022-06-16
JP2022529052A5 true JP2022529052A5 (cg-RX-API-DMAC7.html) 2023-04-24
JP7588859B2 JP7588859B2 (ja) 2024-11-25

Family

ID=70480222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021561852A Active JP7588859B2 (ja) 2019-04-18 2020-04-17 グラム陰性細菌の感染、汚染、及びファウリングを予防及び治療するための新規ピリミジン誘導体

Country Status (10)

Country Link
US (1) US12318388B2 (cg-RX-API-DMAC7.html)
EP (1) EP3955929B1 (cg-RX-API-DMAC7.html)
JP (1) JP7588859B2 (cg-RX-API-DMAC7.html)
KR (1) KR102857084B1 (cg-RX-API-DMAC7.html)
CN (1) CN113329753B (cg-RX-API-DMAC7.html)
AU (1) AU2020258017B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021012834A2 (cg-RX-API-DMAC7.html)
DK (1) DK3955929T3 (cg-RX-API-DMAC7.html)
ES (1) ES2981773T3 (cg-RX-API-DMAC7.html)
WO (1) WO2020212553A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3527571A1 (en) * 2018-02-14 2019-08-21 Université de Liège Pyrimidine derivatives for prevention and treatment of bacterial infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4928399A (en) * 1998-07-27 2000-02-21 M & M Laboratory Co., Ltd. Ion complex, coating material, and coating method
WO2004021979A2 (en) * 2002-09-06 2004-03-18 Smithkline Beecham Corporation PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS
DE102005060690B4 (de) * 2005-12-15 2008-09-25 Capsulution Nanoscience Ag Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen
WO2009034386A1 (en) 2007-09-13 2009-03-19 Astrazeneca Ab Derivatives of adenine and 8-aza-adenine and uses thereof-796
EP2236158A1 (en) * 2009-03-30 2010-10-06 Pharnext New therapeutic approaches for treating neuroinflammatory conditions
WO2010118367A2 (en) * 2009-04-10 2010-10-14 Progenics Pharmaceuticals, Inc. Antiviral pyrimidines
ES2731658T3 (es) 2016-09-09 2019-11-18 Univ Liege Derivados triazolo(4,5-d)pirimidina para uso en la prevención y tratamiento de infección bacteriana
EP3527571A1 (en) 2018-02-14 2019-08-21 Université de Liège Pyrimidine derivatives for prevention and treatment of bacterial infection
GB201910656D0 (en) 2019-07-25 2019-09-11 Univ Liege New use of triazolo(4,5-d)Pyrimidine deerivatives

Similar Documents

Publication Publication Date Title
RU2014120792A (ru) Способ лечения стромальных опухолей желудочно-кишечного тракта
PE20230161A1 (es) Inhibidores de proteinas kras mutantes
CY1113670T1 (el) Φαρμακευτικη συνθεση για τη θεραπεια της υπερδραστηριας ουροδοχου κυστης
JOP20220069A1 (ar) عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها
JP2016527217A5 (cg-RX-API-DMAC7.html)
JP2009541223A5 (cg-RX-API-DMAC7.html)
JP2005536475A5 (cg-RX-API-DMAC7.html)
EA202090977A1 (ru) Новая комбинация активных агентов для лечения прогрессирующих фиброзирующих интерстициальных заболеваний легких (pf-ild)
RU2015148189A (ru) ПРОИЗВОДНЫЕ 2-АМИДОПИРИДО[4, 3-d]ПИРИМИДИН-5-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ WEE-1
JP2020507589A5 (cg-RX-API-DMAC7.html)
RU2019141734A (ru) Терапевтические соединения и композиции и способы их применения
CY1116628T1 (el) Ενωσεις σπειρο-οξινδολιου και χρηση αυτων ως θεραπευτικοι παραγοντες
JP2010533160A5 (cg-RX-API-DMAC7.html)
RU2013121788A (ru) Ингибиторы репликации вич
JP2017515844A5 (cg-RX-API-DMAC7.html)
DK1780197T3 (da) 5-Substituerede 2-phenylamino-benzamider som MEK-inhibitorer
AR038914A1 (es) Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion para fabricar un medicamento
EA202191903A1 (ru) Антипролиферативные соединения и вторые активные агенты для комбинированного применения
JP2018522861A5 (cg-RX-API-DMAC7.html)
JP2015502974A5 (cg-RX-API-DMAC7.html)
JP2015535247A5 (cg-RX-API-DMAC7.html)
BR112015030578A2 (pt) combinações farmacêuticas
JP2010527984A5 (cg-RX-API-DMAC7.html)
WO2014106800A8 (en) Substituted 2-amino pyrimidine derivatives as kinase inhibitors
JP2015521617A5 (cg-RX-API-DMAC7.html)